Chrysin Alters microRNAs Expression Levels in Gastric Cancer Cells: Possible Molecular Mechanism

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Gastric carcinoma is a leading cause of cancer mortality worldwide.
• Chrysin, a naturally occurring flavone, exhibits potential cancer chemopreventive properties.
• The precise molecular mechanisms underlying chrysin's anti-cancer effects require further elucidation.

Purpose of the Study:

• To investigate the impact of chrysin on the expression levels of specific microRNAs (miRNAs) in gastric carcinoma cells.
• To explore the potential role of altered miRNA expression in the anti-cancer effects of chrysin.
• To identify key miRNAs regulated by chrysin treatment in gastric cancer.

Main Methods:

• Cytotoxic effects of chrysin were evaluated using the MTT assay.
• Quantitative real-time PCR (qRT-PCR) was employed to determine miRNA expression levels.
• Gastric carcinoma cell lines were treated with varying concentrations of chrysin.

Main Results:

• The half-maximal inhibitory concentration (IC50) of chrysin was determined to be 68.24 µM after 24 hours of treatment.
• Chrysin treatment led to significant alterations in miRNA expression profiles.
• Specifically, miR-18, miR-21, and miR-221 were downregulated, while let-7a, miR-9, miR-22, miR-34a, and miR-126 were upregulated (p<0.05).

Conclusions:

• Chrysin treatment effectively modulates miRNA expression in gastric cancer cells.
• The observed changes in miRNA expression provide insights into the molecular mechanisms of chrysin's anti-cancer activity.
• These findings suggest that targeting specific miRNAs could be a strategy for gastric cancer therapy with chrysin.